Clinical Trials · NCT04152915
A Research Study Looking at Similarity Between Once-weekly Semaglutide Versions for Different Injection Pens
- Phase
- Phase 1
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 68
- Start date
- Nov 2019
- Locations
- 1 site, Germany
- Primary endpoint
- AUC0-last,sema,1mg: Area under the semaglutide concentration time curve from time 0 until last quantifiable measurement after one dose of s.c. semaglutide 1 mg administration following a 6-week dose escalation period